Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of NID1 mRNA | affects expression | 17562736
|
D000082 |
Acetaminophen |
Acetaminophen results in increased expression of NID1 mRNA | increases expression | 11264010
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NID1 mRNA | affects expression | 16483693
|
D003520 |
Cyclophosphamide |
NID1 protein affects the susceptibility to Cyclophosphamide | affects response to substance | 16217747
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of NID1 mRNA | decreases expression | 20106945
|
D004040 |
Dietary Carbohydrates |
Dietary Carbohydrates results in increased expression of NID1 mRNA | increases expression | 17490981
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of NID1 mRNA | increases expression | 19638242
|
C051890 |
irinotecan |
irinotecan metabolite results in increased expression of NID1 mRNA | increases expression | 15956246
|
C051890 |
irinotecan |
irinotecan results in increased expression of NID1 mRNA | increases expression | 15956246
|
D009151 |
Mustard Gas |
Mustard Gas results in decreased expression of NID1 mRNA | decreases expression | 15674843
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NID1 mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of NID1 mRNA | increases expression | 19482888
|
C009166 |
retinol acetate |
retinol acetate results in increased expression of NID1 mRNA | increases expression | 16772331
|
C010327 |
salinomycin |
salinomycin results in decreased expression of NID1 mRNA | decreases expression | 19682730
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of NID1 mRNA | affects expression | 16507464
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NID1 mRNA | decreases expression | 20106945
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of NID1 mRNA | increases expression | 17138961
|
C025643 |
vinclozolin |
vinclozolin affects the expression of NID1 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
8.46 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.46 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.61 | 18287403 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.87 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
17.66 | 17162532 19061943 16434500 17620307 18056438 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
17.66 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
17.66 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.76 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.96 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.64 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.91 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.66 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.64 | 15014928 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.09 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
5.01 | 10378619 |
MESH:D001249 |
Asthma |
|
Tretinoin |
5.01 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.42 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.44 | 16935849 |
MESH:D001768 |
Blister |
|
Mustard Gas |
5.21 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.03 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.03 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.37 | 15093573 17388661 15136595 12006526 16978400 18323546 18234424 17020986 11325840 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.37 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
salinomycin |
2.37 | 19682730 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.37 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.37 | 16166294 16443354 16873071 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
5.21 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
5.04 | 17687719 10378619 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.64 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.22 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
11.46 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
11.46 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
11.46 | 3084413 20512989 17761372 20432363 17055752 18056438 10672840 16878318 20007298 16830150 18506893 20514400 19208518 18665156 19171122 20935162 17173139 19383236 19919837 20084675 17978847 21159647 19539802 11831363 16569478 16807293 16502159 16681979 16328049 17428255 16288022 17162532 20214788 18785209 19052882 19519916 16935385 10737359 18393292 18691550 19701751 19107877 17138121 18978308 18210153 18788625 20524982 19822196 20727157 20101231 3581430 19394651 19335982 16779866 19418558 16698587 18971187 16540662 18494052 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
11.46 | 20007298 1701930 17173139 6705139 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
11.46 | 16507464 15276417 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
11.46 | 1917145 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.94 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.55 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.71 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.71 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 18850075 18670907 16120746 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.28 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.28 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.30 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
11.30 | 17174075 7505956 21159647 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
11.30 | 20056578 19524636 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.29 | 4080065 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.64 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
9.41 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
9.41 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.94 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.22 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.80 | 12621046 8697196 15668235 15340226 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.80 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.75 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
irinotecan |
2.60 | 17287894 17725105 |
MESH:D015179 |
Colorectal Neoplasms |
|
irinotecan |
2.36 | 16391804 15273666 17454858 17159606 16303861 18259882 18509181 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.45 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.45 | 16925845 9664655 10589399 14991402 17551590 8800419 9211117 9125849 9224671 9142499 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.38 | 14966744 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.05 | 10700343 11948286 17010015 10498854 18483878 16989017 16651033 12388444 18710439 16614059 18295254 18372110 12161096 18093676 15643279 12913760 17979934 16413132 15276878 18433785 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.09 | 15331540 11751995 10990075 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.23 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.24 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.24 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.17 | 11461765 12958197 19416960 12392966 12705907 11421492 10915739 16393943 16109766 19164858 11834606 17562736 14725611 10663392 16781746 19370779 19739265 19420014 17906064 12594235 16081117 19923254 14550746 12153990 16227642 2444490 19085960 10774834 11739529 16485898 11743745 18713872 11287661 15619225 14986274 11529661 16177239 17522070 18071297 12540782 15968718 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.17 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.17 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.16 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.04 | 1851702 |
MESH:D004487 |
Edema |
|
Mustard Gas |
6.94 | 11428647 11402378 9260866 11428631 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.94 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.16 | 15322242 16714409 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.16 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.12 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 9294722 10568697 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.26 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.15 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.93 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.90 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.57 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.29 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.07 | 3659116 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
5.21 | 9357497 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.18 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.90 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.90 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.81 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
7.81 | 20387270 21071580 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
14.98 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.98 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.98 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.74 | 16983495 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.98 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.36 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.73 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.02 | 17312396 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.56 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.08 | 16376943 15172196 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.20 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.22 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.58 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.58 | 9664655 14991402 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.33 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.60 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
8.58 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.58 | 12621046 16120746 15340226 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
7.70 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
7.70 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 18606429 15340226 16959395 8697196 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
7.70 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
7.70 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.61 | 16778211 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.98 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.98 | 18670907 18850075 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.39 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
11.47 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
11.47 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
11.47 | 16467254 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.41 | 18785209 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
8.41 | 11428631 11428647 17524151 16001271 11402378 9357497 11428620 8975870 9260866 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.41 | 12200463 12878042 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.81 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.03 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.03 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
10.10 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.10 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
10.10 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.76 | 12371664 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
6.63 | 10602166 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.63 | 17143497 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.51 | 17802794 18172266 18587576 17296974 17658394 17008537 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.11 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.73 | 19285840 16482212 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.08 | 17596541 19850784 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.17 | 17368321 17506722 17301526 17294898 17712046 17361223 9834237 19035177 16766008 12679006 16331271 16823087 16935935 17107899 17217047 17339181 15748426 19642359 16140955 19075265 17649720 19225113 16891316 16788101 19029980 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.02 | 10052129 11830472 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.78 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.33 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.69 | 20032147 19638242 18522880 18665156 18407596 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.69 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.31 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.31 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.53 | 19014921 16611625 19460945 11587558 19784758 16610002 12969438 12587719 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.53 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.53 | 19363144 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.26 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
10.79 | 15175105 19833225 12771043 19255062 19254457 20405173 19426721 21071580 20137499 2422723 21278145 20501860 19812893 19294768 19638242 19073162 19427195 19642983 19499222 18978307 19690152 9163691 20452335 19090486 16942905 21047994 18648771 20118626 18977376 19996281 12112319 19850985 18754104 2862719 20101389 15885732 18644402 20492335 19551842 20434301 19256749 10737359 20583210 21167192 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
10.79 | 21047994 19073162 19812893 15975961 19482888 8742319 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
10.79 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.79 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
9.91 | 16842330 18544905 19539802 18253720 19009564 18164116 16267830 19126423 18308698 18079962 19004024 18775883 2563599 18282651 17942915 21159647 19519916 17174075 17854601 3124819 9362446 18093689 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
9.91 | 2563599 1399818 6150874 17172636 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.91 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
7.60 | 18702808 18161513 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.60 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
4.88 | 20970405 20512841 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
4.88 | 8781369 3148597 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.88 | 17077188 19931552 17306315 16712894 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.88 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
3.86 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.63 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.19 | 11911406 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
salinomycin |
3.78 | 19682730 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.79 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.35 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.35 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
10.97 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
10.97 | 16388313 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.47 | 16940565 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D052016 |
Mucositis |
|
irinotecan |
5.06 | 17159606 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.09 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.53 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.99 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
irinotecan |
5.99 | 18259882 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
8.47 | 18854779 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.47 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.47 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.71 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.63 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.63 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.37 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.37 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
7.34 | 8761367 16115947 15176712 |
MESH:D009447 |
Neuroblastoma |
|
irinotecan |
7.34 | 8761367 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.26 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.26 | 20387270 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
11.71 | 12837982 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
irinotecan |
11.71 | 8761367 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.18 | 20387270 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
9.64 | 8291058 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
9.64 | 7688884 16761898 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.76 | 16517039 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.41 | 17016548 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.91 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.91 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
11.43 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
11.43 | 12161096 18093676 |
MESH:D010146 |
Pain |
|
Tretinoin |
11.43 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
12.44 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
12.44 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
12.44 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
12.44 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.83 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
15.42 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
15.42 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
15.42 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.82 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.66 | 11896295 11118676 11222880 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
9.66 | 18042343 19015723 18220299 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.98 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
3.54 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.54 | 16039940 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.98 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.64 | 16636307 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
4.14 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.56 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.84 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
6.04 | 16636934 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
6.04 | 10334151 17266442 17620002 17894541 17720292 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.13 | 16116481 16283617 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.85 | 16636934 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.71 | 3137016 11442880 4039156 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.87 | 6407741 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.72 | 16961503 12880345 15451306 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.50 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.50 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.50 | 16467112 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.56 | 16517039 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.82 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
3.45 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
irinotecan |
3.45 | 15723263 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.45 | 17261132 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.11 | 12837982 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
12.10 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
12.10 | 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
12.10 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.81 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.24 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
5.44 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.44 | 16452187 17306315 11723127 16712894 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.01 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.50 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.50 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.67 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.47 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.09 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.99 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |